As life expectancy continues to increase in this population with the use of CFTR modulators, non-traditional nutrition issues have emerged, and overweight/obesity have become areas of interest in CF clinical care and research. The gene discussed is CFTR; the disease is obesity due to melanocortin 4 receptor deficiency.